Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
| Study Number Sort descending | Lead Group | Study Title | CIRB | Study Status | |
|---|---|---|---|---|---|
| CALGB-80802 | CALGB | Phase III Randomized Study of Sorafenib Plus Doxorubicin Versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC) | Adult CIRB - Late Phase Emphasis | Available to Open | |
| CALGB-90104 | CALGB | A Randomized Phase III Study Comparing Sequential Chemotherapy (AG-TP) to Cisplatin and Gemcitabine as Adjuvant Treatment After Cystectomy for Transitional Cell Carcinoma of the Bladder | Adult CIRB - Late Phase Emphasis | Completed | |
| CALGB-90106 | CALGB | A Randomized Phase III Study of Paclitaxel; Ifosfamide and Cisplatin Versus Vinblastine; Ifosfamide and Cisplatin as Second-Line Therapy for Patients with Relapsed/Resistant Germ Cell Tumors | Adult CIRB - Late Phase Emphasis | Completed | |
| CALGB-90202 | CALGB | A Randomized Double-Blind; Placebo-Controlled Phase III Study of Early Versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men with Prostate Cancer Metastatic to Bone | Adult CIRB - Late Phase Emphasis | Completed | |
| CALGB-90203 | CALGB | A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients with High-Risk; Clinically Localized Prostate Cancer | Adult CIRB - Late Phase Emphasis | Available to Open | |
| CALGB-90206 | CALGB | A Randomized Phase III Trial of Interferon Alfa-2B or Interferon Alfa-2B Plus Bevacizumab in Patients with Advanced Renal Carcinoma | Adult CIRB - Late Phase Emphasis | Completed | |
| CALGB-90401 | CALGB | A Randomized Double-Blinded Placebo Controlled Phase III Trial Comparing Docetaxel and Prednisone with and without Bevacizumab (IND #7921; NSC #704865) in Men with Hormone Refractory Prostate Cancer | Adult CIRB - Late Phase Emphasis | Completed | |
| CALGB-90601 | CALGB | A Randomized Double-Blinded Phase III Study Comparing Gemcitabine; Cisplatin; and Bevacizumab to Gemcitabine; Cisplatin; and Placebo in Patients with Advanced Transitional Cell Carcinoma | Adult CIRB - Late Phase Emphasis | Completed | |
| CALGB-90802 | CALGB | Randomized Phase III Trial Comparing Everolimus Versus Everolimus Plus Bevacizumab for Advanced Renal Cell Carcinoma Progressing After Treatment with Tyrosine Kinase Inhibitors | Adult CIRB - Late Phase Emphasis | Completed | |
| CCTG CE.7 | NCIC CTG | A Phase III Trial of Stereotactic Radiosurgery Compared with Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5-15 Brain Metastases | Adult CIRB - Late Phase Emphasis | Available to Open |